Applications of Nuclear Magnetic Resonance and Mass Spectrometry to Anticancer Drug Discovery

Robert Powers, Marshall M. Siegel

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

This chapter discusses the applications of nuclear magnetic resonance and mass spectrometry to anticancer drug discovery. Nuclear magnetic resonance (NMR) provides a plethora of tools that can be applied to address a number of issues or questions that typically occur during a drug development program. NMR is routinely used to determine high-resolution structures of proteins and protein-ligand complexes. Additionally, NMR can provide valuable information on the dynamic behavior of the same proteins and protein-ligand complexes. These data are essential to a structure-based drug discovery program. NMR has been used to address a fundamental issue associated with the drug discovery process, namely, to verify that a chemical lead actually binds in a biologically relevant manner to the protein target of interest. A variety of NMR techniques, including 2D heteronuclear single quantum coherence, saturation transfer difference, and 1D line-broadening, have been successfully applied to screening compound libraries by NMR. A variety of MS techniques have been used for structure elucidation, analysis of metabolism, diagnostics, and drug screening. It is found that the parallel development of MS as a technique to screen libraries for compounds that bind biomoleules and the complementary nature of NMR and MS lead to the development of the MS/NMR assay by combining the inherent strengths of these analytical techniques.

Original languageEnglish (US)
Title of host publicationNovel Anticancer Agents
PublisherElsevier Inc.
Pages107-190
Number of pages84
ISBN (Print)9780120885619
DOIs
StatePublished - Dec 1 2006

Fingerprint

Drug Discovery
Mass spectrometry
Mass Spectrometry
Magnetic Resonance Spectroscopy
Nuclear magnetic resonance
Proteins
Libraries
Screening
Ligands
Preclinical Drug Evaluations
Metabolism
Pharmaceutical Preparations
Assays

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Applications of Nuclear Magnetic Resonance and Mass Spectrometry to Anticancer Drug Discovery. / Powers, Robert; Siegel, Marshall M.

Novel Anticancer Agents. Elsevier Inc., 2006. p. 107-190.

Research output: Chapter in Book/Report/Conference proceedingChapter

Powers, Robert ; Siegel, Marshall M. / Applications of Nuclear Magnetic Resonance and Mass Spectrometry to Anticancer Drug Discovery. Novel Anticancer Agents. Elsevier Inc., 2006. pp. 107-190
@inbook{f1e371b3b40b4e5b8b7c630bf867ce8e,
title = "Applications of Nuclear Magnetic Resonance and Mass Spectrometry to Anticancer Drug Discovery",
abstract = "This chapter discusses the applications of nuclear magnetic resonance and mass spectrometry to anticancer drug discovery. Nuclear magnetic resonance (NMR) provides a plethora of tools that can be applied to address a number of issues or questions that typically occur during a drug development program. NMR is routinely used to determine high-resolution structures of proteins and protein-ligand complexes. Additionally, NMR can provide valuable information on the dynamic behavior of the same proteins and protein-ligand complexes. These data are essential to a structure-based drug discovery program. NMR has been used to address a fundamental issue associated with the drug discovery process, namely, to verify that a chemical lead actually binds in a biologically relevant manner to the protein target of interest. A variety of NMR techniques, including 2D heteronuclear single quantum coherence, saturation transfer difference, and 1D line-broadening, have been successfully applied to screening compound libraries by NMR. A variety of MS techniques have been used for structure elucidation, analysis of metabolism, diagnostics, and drug screening. It is found that the parallel development of MS as a technique to screen libraries for compounds that bind biomoleules and the complementary nature of NMR and MS lead to the development of the MS/NMR assay by combining the inherent strengths of these analytical techniques.",
author = "Robert Powers and Siegel, {Marshall M.}",
year = "2006",
month = "12",
day = "1",
doi = "10.1016/B978-012088561-9/50006-5",
language = "English (US)",
isbn = "9780120885619",
pages = "107--190",
booktitle = "Novel Anticancer Agents",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Applications of Nuclear Magnetic Resonance and Mass Spectrometry to Anticancer Drug Discovery

AU - Powers, Robert

AU - Siegel, Marshall M.

PY - 2006/12/1

Y1 - 2006/12/1

N2 - This chapter discusses the applications of nuclear magnetic resonance and mass spectrometry to anticancer drug discovery. Nuclear magnetic resonance (NMR) provides a plethora of tools that can be applied to address a number of issues or questions that typically occur during a drug development program. NMR is routinely used to determine high-resolution structures of proteins and protein-ligand complexes. Additionally, NMR can provide valuable information on the dynamic behavior of the same proteins and protein-ligand complexes. These data are essential to a structure-based drug discovery program. NMR has been used to address a fundamental issue associated with the drug discovery process, namely, to verify that a chemical lead actually binds in a biologically relevant manner to the protein target of interest. A variety of NMR techniques, including 2D heteronuclear single quantum coherence, saturation transfer difference, and 1D line-broadening, have been successfully applied to screening compound libraries by NMR. A variety of MS techniques have been used for structure elucidation, analysis of metabolism, diagnostics, and drug screening. It is found that the parallel development of MS as a technique to screen libraries for compounds that bind biomoleules and the complementary nature of NMR and MS lead to the development of the MS/NMR assay by combining the inherent strengths of these analytical techniques.

AB - This chapter discusses the applications of nuclear magnetic resonance and mass spectrometry to anticancer drug discovery. Nuclear magnetic resonance (NMR) provides a plethora of tools that can be applied to address a number of issues or questions that typically occur during a drug development program. NMR is routinely used to determine high-resolution structures of proteins and protein-ligand complexes. Additionally, NMR can provide valuable information on the dynamic behavior of the same proteins and protein-ligand complexes. These data are essential to a structure-based drug discovery program. NMR has been used to address a fundamental issue associated with the drug discovery process, namely, to verify that a chemical lead actually binds in a biologically relevant manner to the protein target of interest. A variety of NMR techniques, including 2D heteronuclear single quantum coherence, saturation transfer difference, and 1D line-broadening, have been successfully applied to screening compound libraries by NMR. A variety of MS techniques have been used for structure elucidation, analysis of metabolism, diagnostics, and drug screening. It is found that the parallel development of MS as a technique to screen libraries for compounds that bind biomoleules and the complementary nature of NMR and MS lead to the development of the MS/NMR assay by combining the inherent strengths of these analytical techniques.

UR - http://www.scopus.com/inward/record.url?scp=84871282959&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871282959&partnerID=8YFLogxK

U2 - 10.1016/B978-012088561-9/50006-5

DO - 10.1016/B978-012088561-9/50006-5

M3 - Chapter

SN - 9780120885619

SP - 107

EP - 190

BT - Novel Anticancer Agents

PB - Elsevier Inc.

ER -